The beneficial effects of high-density lipoprotein on adipocytes may relate to its anti-atherogenic properties

Medical Hypotheses

Volumn 67, Issue 5, 2006, Pages 1195-1199

  Wu, Zhi hong ^a   Zhao, Shui ping ^a   Ye, Hui jun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CYTOKINE PRODUCTION; HUMAN; INFLAMMATION; LIPID STORAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ADIPOCYTES; ADIPOKINES; ADIPOSE TISSUE; ADULT; AGED; ATHEROSCLEROSIS; CHOLESTEROL, HDL; CORONARY DISEASE; FEMALE; HUMANS; LEPTIN; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; RISK FACTORS;

EID: 33748034066     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.03.052     Document Type: Article

References (50)

1. Boden W.E. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the veterans affairs high-density lipoprotein intervention trial. Am J Cardiol 86 (2000) 19L-22L
2. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: p. 2486-97.
3. Lewis G.F., and Rader D.J. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96 (2005) 1221-1232
4. Assmann G., and Gotto Jr. A.M. HDL cholesterol and protective factors in atherosclerosis. Circulation 109 (2004) III8-14
5. Kuvin J.T., Alsheikh-Ali A.A., and Karas R.H. High-density lipoprotein cholesterol-raising strategies. J Cardiovasc Pharmacol 47 (2006) 196-204
6. Jin W., Marchadier D., and Rader D.J. Lipases and HDL metabolism. Trends Endocrinol Metab 13 (2002) 174-178
7. Calabresi L., Gomaraschi M., and Franceschini G. Endothelial protection by high-density lipoproteins: from bench to bedside. Arterioscler Thromb Vasc Biol 23 (2003) 1724-1731
8. Boucher J., Castan-Laurell I., Daviaud D., et al. Adipokine expression profile in adipocytes of different mouse models of obesity. Horm Metab Res 37 (2005) 761-767
9. Trayhurn P., and Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92 (2004) 347-355
10. Lyon C.J., Law R.E., and Hsueh W.A. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144 (2003) 2195-2200
11. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
12. Lau D.C., Dhillon B., Yan H., et al. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 288 (2005) H2031-H2041
13. Wu Z.H., and Zhao S.P. Adipocyte: a potential target for the treatment of atherosclerosis. Med Hypotheses 67 (2006) 82-86
14. Wallace A.M., McMahon A.D., Packard C.J., et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104 (2001) 3052-3056
15. Oda A., Taniguchi T., and Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 47 (2001) 141-150
16. Parhami F., Tintut Y., Ballard A., Fogelman A.M., and Demer L.L. Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 88 (2001) 954-960
17. Yamagishi S.I., Edelstein D., Du X.L., Kaneda Y., Guzman M., and Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 276 (2001) 25096-25100
18. O'Rourke L., Gronning L.M., Yeaman S.J., et al. Glucose-dependent regulation of cholesterol ester metabolism in macrophages by insulin and leptin. J Biol Chem 277 (2002) 42557-42562
19. Cooke J.P., and Oka R.K. Does leptin cause vascular disease?. Circulation 106 (2002) 1904-1905
20. Konstantinides S., Schafer K., Koschnick S., et al. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 108 (2001) 1533-1540
21. Nedvidkova J., Smitka K., Kopsky V., et al. Adiponectin, an adipocyte-derived protein. Physiol Res 54 (2005) 133-140
22. Pischon T., Girman C.J., Hotamisligil G.S., et al. JAMA 291 (2004) 1730-1737
23. Kumada M., Kihara S., Sumitsuji S., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23 (2003) 85-89
24. Kubota N., Terauchi Y., Yamauchi T., et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277 (2002) 25863-25866
25. Okamoto Y., Kihara S., Ouchi N., et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106 (2002) 2767-2770
26. Goldstein B.J., and Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89 (2004) 2563-2568
27. Ouchi N., Kihara S., Funahashi T., et al. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 14 (2003) 561-566
28. Steppan C.M., Bailey S.T., Bhat S., et al. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
29. Pang S.S., and Le Y.Y. Role of resistin in inflammation and inflammation-related diseases. Cell Mol Immunol 3 (2006) 29-34
30. Pischon T., Bamberger C.M., Kratzsch J., et al. Association of plasma resistin levels with coronary heart disease in women. Obes Res 13 (2005) 1764-1771
31. Reilly M.P., Lehrke M., Wolfe M.L., et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111 (2005) 932-939
32. Burnett M.S., Lee C.W., Kinnaird T.D., et al. The potential role of resistin in atherogenesis. Atherosclerosis 182 (2005) 241-248
33. Calabro P., Samudio I., Willerson J.T., et al. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 110 (2004) 3335-3340
34. Diamond Jr. F.B., Cuthbertson D., Hanna S., et al. Correlates of adiponectin and the leptin/adiponectin ratio in obese and non-obese children. J Pediatr Endocrinol Metab 17 (2004) 1069-1075
35. Chu N.F., Shen M.H., Wu D.M., et al. Relationship between plasma adiponectin levels and metabolic risk profiles in Taiwanese children. Obes Res 13 (2005) 2014-2020
36. Yamamoto Y., Hirose H., Saito I., et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 103 (2002) 137-142
37. Shetty G.K., Economides P.A., Horton E.S., et al. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diab Care 27 (2004) 2450-2457
38. Dunajska K., Milewicz A., Jedrzejuk D., et al. Plasma adiponectin concentration in relation to severity of coronary atherosclerosis and cardiovascular risk factors in middle-aged men. Endocrine 25 (2004) 215-221
39. Rothenbacher D., Brenner H., Marz W., et al. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J 26 (2005) 1640-1646
40. Tamer L., Ercan B., Unlu A., et al. The relationship between leptin and lipids in atherosclerosis. Indian Heart J 54 (2002) 692-696
41. Matsubara M., Chiba H., Maruoka S., et al. Elevated serum leptin concentrations in women with components of multiple risk factor clustering syndrome. J Atheroscler Thromb 7 (2000) 231-237
42. Holub M., Zwiauer K., Winkler C., et al. Relation of plasma leptin to lipoproteins in overweight children undergoing weight reduction. Int J Obes Relat Metab Disord 23 (1999) 60-66
43. Matsubara M., Maruoka S., and Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 147 (2002) 173-180
44. Chen C.C., Li T.C., Li C.I., et al. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. Metabolism 54 (2005) 471-475
45. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21 (2000) 697-738
46. Yang W.S., Lee W.J., Funahashi T., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86 (2001) 3815-3819
47. Tontonoz P., Hu E., and Spiegelman B.M. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr Opin Genet Dev 5 (1995) 571-576
48. Lehrke M., and Lazar M.A. The many faces of PPARgamma. Cell 123 (2005) 993-999
49. Amri E.Z., Bertrand B., Ailhaud G., et al. Regulation of adipose cell differentiation. I. Fatty acids are inducers of the aP2 gene expression. J Lipid Res 32 (1991) 1449-1456
50. Han J., Hajjar D.P., Zhou X., et al. Regulation of peroxisome proliferator-activated receptor-gamma-mediated gene expression. A new mechanism of action for high density lipoprotein. J Biol Chem 277 (2002) 23582-23586